SCM
IRON icon

Suvretta Capital Management’s Disc Medicine IRON Stock Holding History

Suvretta Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80,000
Closed -$3.97M – 102
2025
Q1 		$3.97M Buy
+80,000
New +$4.45M 0.16% 66
2022
Q4 		– Sell
-79,076
Closed -$3.89M – 95
2022
Q3 		$3.89M Hold
79,076
– – 0.16% 60
2022
Q2 		$4.01M Hold
79,076
– – 0.15% 68
2022
Q1 		$3.3M Hold
79,076
– – 0.1% 69
2021
Q4 		$6.9M Buy
79,076
+7,815
+11% +$766K 0.13% 68
2021
Q3 		$8.64M Buy
71,261
+94
+0.1% +$12.8K 0.15% 68
2021
Q2 		$13.8M Buy
71,167
+27,422
+63% +$9.02M 0.21% 71
2021
Q1 		$17.8M Buy
+43,745
New +$19.5M 0.26% 62

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return